ORIGINAL RESEARCH
Accepted on 22 Sep 2025
Effective MRD Clearance and Long-Term Survival with CD19 CAR-T in Pediatric B-ALL Patients with MRD Positivity or Chemotherapy Intolerance
doi 10.3389/fimmu.2025.1672509
- 225 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Genetically Engineered T cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future Directions
Genetically Engineered T cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future Directions
905
Total downloads
6,504
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 15 May 2025
Bispecific antibody targeting shared indel-derived neoantigen of APC
doi 10.3389/fimmu.2025.1574958
- 2,379 views
ORIGINAL RESEARCH
Published on 15 May 2025
Identification of shared neoantigens derived from frameshift mutations in the APC gene
doi 10.3389/fimmu.2025.1574955
- 2,432 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
T Cell Biology
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: